Neutrophil-induced genomic instability impedes resolution of inflammation and wound healing.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
01 02 2019
Historique:
received: 11 05 2018
accepted: 20 11 2018
pubmed: 15 1 2019
medline: 18 12 2019
entrez: 15 1 2019
Statut: ppublish

Résumé

Neutrophil (PMN) infiltration of the intestinal mucosa is a hallmark of tissue injury associated with inflammatory bowel diseases (IBDs). The pathological effects of PMNs are largely attributed to the release of soluble mediators and reactive oxygen species (ROS). We identified what we believe is a new, ROS-independent mechanism whereby activated tissue-infiltrating PMNs release microparticles armed with proinflammatory microRNAs (miR-23a and miR-155). Using IBD clinical samples, and in vitro and in vivo injury models, we show that PMN-derived miR-23a and miR-155 promote accumulation of double-strand breaks (DSBs) by inducing lamin B1-dependent replication fork collapse and inhibition of homologous recombination (HR) by targeting HR-regulator RAD51. DSB accumulation in injured epithelium led to impaired colonic healing and genomic instability. Targeted inhibition of miR-23a and miR-155 in cultured intestinal epithelial cells and in acutely injured mucosa decreased the detrimental effects of PMNs and enhanced tissue healing responses, suggesting that this approach can be used in therapies aimed at resolution of inflammation, in wound healing, and potentially to prevent neoplasia.

Identifiants

pubmed: 30640176
pii: 122085
doi: 10.1172/JCI122085
pmc: PMC6355304
doi:
pii:

Substances chimiques

MIRN155 microRNA, human 0
MIRN23a microRNA, human 0
MicroRNAs 0
Mirn155 microRNA, mouse 0
Mirn23b microRNA, mouse 0
Reactive Oxygen Species 0
RAD51 protein, human EC 2.7.7.-
Rad51 Recombinase EC 2.7.7.-
Rad51 protein, mouse EC 2.7.7.-

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

712-726

Subventions

Organisme : NIDDK NIH HHS
ID : K01 DK101675
Pays : United States
Organisme : NIDDK NIH HHS
ID : K08 DK106456
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA060553
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK084567
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

World J Gastroenterol. 2008 Jan 21;14(3):348-53
pubmed: 18200658
Mol Cancer Res. 2013 Dec;11(12):1564-73
pubmed: 24088786
Nat Rev Cancer. 2015 Jun;15(6):321-33
pubmed: 25998712
FASEB J. 2016 Dec;30(12):4007-4020
pubmed: 27553226
Mol Cell Biol. 2002 Sep;22(17):6306-17
pubmed: 12167722
Nat Rev Immunol. 2014 Mar;14(3):195-208
pubmed: 24566916
Curr Protoc Immunol. 2014 Feb 04;104:15.25.1-15.25.14
pubmed: 24510619
Anticancer Res. 2016 Apr;36(4):1447-60
pubmed: 27069120
Mol Cell Biol. 2015 Mar;35(5):884-98
pubmed: 25535332
Nat Rev Mol Cell Biol. 2010 Mar;11(3):220-8
pubmed: 20177397
Nat Rev Immunol. 2013 Mar;13(3):159-75
pubmed: 23435331
Annu Rev Genet. 2015;49:291-313
pubmed: 26436461
EMBO Rep. 2012 Jun 01;13(6):515-27
pubmed: 22614003
J Immunol. 2017 Apr 1;198(7):2886-2897
pubmed: 28242649
EMBO J. 2014 Aug 1;33(15):1698-712
pubmed: 24966277
Br J Cancer. 2016 May 24;114(11):1180-4
pubmed: 27140310
J Cell Biol. 2013 Mar 4;200(5):605-17
pubmed: 23439683
Inflamm Bowel Dis. 2013 Jun;19(7):1556-65
pubmed: 23598816
Endocr Metab Immune Disord Drug Targets. 2014;14(3):210-7
pubmed: 25051983
Nature. 2015 Nov 5;527(7576):105-9
pubmed: 26524528
Nat Rev Genet. 2012 Jan 24;13(3):189-203
pubmed: 22269907
PLoS One. 2013 Jul 24;8(7):e69169
pubmed: 23894423
Tissue Barriers. 2018;6(2):e1431038
pubmed: 29424657
Nat Med. 2015 Dec;21(12):1424-35
pubmed: 26646499
Trends Biochem Sci. 2011 Sep;36(9):478-84
pubmed: 21741842
Proc Soc Exp Biol Med. 1997 Apr;214(4):318-27
pubmed: 9111522
Nat Rev Cancer. 2016 Jan;16(1):20-33
pubmed: 26678314
Nature. 2007 Jul 26;448(7152):427-34
pubmed: 17653185
Curr Med Chem. 2012;19(26):4431-44
pubmed: 22830332
PLoS One. 2013;8(2):e55775
pubmed: 23409039
Nat Rev Mol Cell Biol. 2013 Mar;14(3):181-9
pubmed: 23385724
Nat Commun. 2015 Apr 10;6:6790
pubmed: 25858675
Genes Dev. 2007 Dec 15;21(24):3342-55
pubmed: 18079180
Nat Rev Mol Cell Biol. 2014 Jun;15(6):411-21
pubmed: 24854789
Nature. 2007 Jun 21;447(7147):941-50
pubmed: 17581577
Nat Rev Immunol. 2010 Feb;10(2):111-22
pubmed: 20098459
Nat Rev Mol Cell Biol. 2008 Apr;9(4):297-308
pubmed: 18285803
Nat Rev Rheumatol. 2014 Jun;10(6):356-64
pubmed: 24535546
J Cell Biol. 1996 Dec;135(6 Pt 1):1441-55
pubmed: 8978814
Cold Spring Harb Perspect Biol. 2013 Feb 01;5(2):
pubmed: 23378590
Biochim Biophys Acta. 2013 Feb;1830(2):2345-53
pubmed: 22995214
Trends Cell Biol. 2016 Jan;26(1):52-64
pubmed: 26437586
Nat Immunol. 2016 Mar;17(3):230-40
pubmed: 26882261
Curr Opin Cell Biol. 2005 Dec;17(6):568-75
pubmed: 16226452
Carcinogenesis. 2009 Jan;30(1):2-10
pubmed: 18978338
J Vis Exp. 2018 Mar 2;(133):
pubmed: 29553513
Cell. 1987 Nov 6;51(3):383-92
pubmed: 3311384
Nat Rev Mol Cell Biol. 2015 Apr;16(4):207-20
pubmed: 25714681
World J Gastroenterol. 2012 Jun 14;18(22):2745-55
pubmed: 22719182
Genes Dev. 2011 Dec 15;25(24):2579-93
pubmed: 22155925
Front Genet. 2016 Aug 09;7:147
pubmed: 27555866
Nat Rev Mol Cell Biol. 2010 Oct;11(10):683-7
pubmed: 20842177
Microbes Infect. 2014 Oct;16(10):822-32
pubmed: 25449753
Sci Transl Med. 2017 Sep 20;9(408):
pubmed: 28931657
Trends Genet. 2012 Sep;28(9):464-71
pubmed: 22795640
Nat Rev Mol Cell Biol. 2014 Aug;15(8):509-24
pubmed: 25027649
J Clin Invest. 2015 Mar 2;125(3):1215-27
pubmed: 25664854
Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4536-41
pubmed: 24616504
Nat Rev Genet. 2016 Dec;17(12):719-732
pubmed: 27795564
Cell Mol Life Sci. 2017 Mar;74(5):803-826
pubmed: 27624395
Mol Cell Biol. 1999 Apr;19(4):2986-97
pubmed: 10082566
Mutagenesis. 2006 Jul;21(4):225-36
pubmed: 16870698
Mol Cell Proteomics. 2013 Aug;12(8):2205-19
pubmed: 23660474
Nat Rev Clin Oncol. 2015 Oct;12(10):584-96
pubmed: 26122183
Nature. 2011 Jun 15;474(7351):298-306
pubmed: 21677746
Nat Rev Mol Cell Biol. 2014 Jul;15(7):482-96
pubmed: 24954210

Auteurs

Veronika Butin-Israeli (V)

Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Triet M Bui (TM)

Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Hannah L Wiesolek (HL)

Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Lorraine Mascarenhas (L)

Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Joseph J Lee (JJ)

Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Lindsey C Mehl (LC)

Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Kaitlyn R Knutson (KR)

Enteric Neuroscience Program, Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, USA.

Stephen A Adam (SA)

Department of Cell and Molecular Biology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Robert D Goldman (RD)

Department of Cell and Molecular Biology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Arthur Beyder (A)

Enteric Neuroscience Program, Division of Gastroenterology & Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Department of Physiology & Biomedical Engineering, Mayo Clinic, Rochester, Minnesota, USA.

Lisa Wiesmuller (L)

Department of Obstetrics and Gynecology, Ulm University, Ulm, Germany.

Stephen B Hanauer (SB)

Northwestern Memorial Hospital, Chicago, Illinois, USA.

Ronen Sumagin (R)

Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH